InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,848.71
(
0.08%
)
Post# of 251798
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: pcrutch post# 132856

Friday, 12/16/2011 3:46:21 AM

Friday, December 16, 2011 3:46:21 AM

Post# of 251798
Highlight of ASH was the MD Anderson guys presenting their institutions history with ruxo showing a survival advantage. They really went after the Mayo data. Was a hoot.

I'm not normally a fan of MDACC (see also Advexin), but it's nice to see someone having enough courage to call out (in a public, peer-reviewed format) crappy data from another institution. Much better than the silent backstabbing that usually goes on...

Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up